YDES · YD Bio Ltd
United States · RS rating 60 · As of 2026-11-03
| Price | 6.39 USD |
|---|---|
| 1-day change | +7.1% |
| RS rating (overall / 1M / 3M / 12M) | 60 / 35 / 97 / 24 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 19 / 17 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +58.5% |
| Market cap (USD) | $369.9M |